Adverse Event | Infliximab, n = 48 | Adalimumab, n = 43 |
---|---|---|
Major AE | 0 | 0 |
Minor AE | 9 (18.7) | 2 (4.7) |
Infections | 3 | 0 |
Upper respiratory tract | 1 | 0 |
Herpes zoster virus | 1 | 0 |
Urinary tract | 1 | 0 |
Infusion reactions | 3 | 0 |
Systemic symptoms | 3 | 2 |
Headache | 2 | 0 |
Irritability | 1 | 0 |
Urticarial rash | 0 | 1 |
Prolonged menses | 0 | 1 |